XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A P/E Ratio

The latest P/E ratio for XOMAP is 24.35. That is below the Healthcare sector average of 26.85. Investors often review this figure alongside XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, XOMAP currently prints 24.35 for P/E ratio, while the sector average sits near 26.85. That is roughly 9.3% below the sector mean. Large gaps often invite a closer look at XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's growth, margins, and balance sheet.

A P/E ratio of 24.35 for XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A is not 'good' or 'bad' on its own. Compare it with the peer average (26.85) and with XOMAP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting XOMAP's P/E ratio (24.35), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.